Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cell Biomaterials is Scopus-indexed (Q3, CiteScore 2.9). Published by Cell Press.
Checked against the index lists dated .
ISSN 3050-5623Verify ISSN ↗
Publisher: Cell Press
Cost to publish: About US$9,350 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 217 / 342 | 36th | Q3 |
| Chemistry (miscellaneous) | 93 / 137 | 32nd | Q3 |
| Biomaterials | 102 / 146 | 30th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2025–present, best quartile Q3, CiteScore 2.9.
Cell Biomaterials is Q3 in Biomedical Engineering (rank 217 of 342), Q3 in Chemistry (miscellaneous) (rank 93 of 137) and Q3 in Biomaterials (rank 102 of 146), by CiteScore 2025.
Cell Biomaterials is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.9, quartile Q3, 36th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
The publisher lists an article processing charge of about US$9,350 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cell Biomaterials is published by Cell Press. Its ISSN is 3050-5623.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cell Biomaterials has an h-index of 18 and a 2-year mean of 5.09 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q3. On 2-year citations it ranks #76 of 322 Scopus journals in Biomedical Engineering.
Cell Biomaterials published 157 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2026), authors are most often from United States (43.4%), China (29%) and Japan (5.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.